Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / C•••••• H•••••

C•••••• H•••••

Series BUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$50.0Msum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Apr 22, 2026
    Series B · $50.0M (disclosed)
    O•• H• (lead)W••••••••• M••••••••• L•• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “C•••••• H••••• Raises $50 Million Series B to Revolutionize the Biopharma Patient Experience”
Investors on record
2 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Apr 22, 2026
    C•••••• H••••• announced Series B of $50,000,000, led by O•• H•
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company